Journal ArticleDOI
Self-designing clinical trials.
Reads0
Chats0
TLDR
A method of sequential analysis for randomized clinical trials that allows use of all prior data in a trial to determine the use and weighting of subsequent observations is presented.Abstract:
I present a method of sequential analysis for randomized clinical trials that allows use of all prior data in a trial to determine the use and weighting of subsequent observations. One continues to assign subjects until one has 'used up' all the variance of the test statistic. There are many strategies to determine the weights including Bayesian methods (though the proposal is a frequentist design). I explore further the self-designing aspect of the randomized trial to note that in some cases it makes good sense (i) to change the weighting on components of a multivariate endpoint, (ii) to add or drop treatment arms (especially in a parallel group dose ranging/efficacy/safety trial), (iii) to select sites to use as the trial goes on, (iv) to change the test statistic and (v) even to rethink the whole drug development paradigm to shorten drug development time while keeping current standards for the level of evidence necessary for approval.read more
Citations
More filters
Book
Multiple Comparisons Using R
TL;DR: In this article, the multcomp package is used for multiple comparisons with a control and all pairwise comparisons with the same pairwise comparison, under the assumption of heteroscedasticity.
Journal ArticleDOI
An experimental design for the development of adaptive treatment strategies
TL;DR: This paper advocates the use of sequential multiple assignment randomized trials in the development of adaptive treatment strategies and both a simple ad hoc method for ascertaining sample sizes and simple analysis methods are provided.
Journal ArticleDOI
Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches
Hans-Helge Müller,Helmut Schäfer +1 more
TL;DR: A general method is presented integrating the concept of adaptive interim analyses into classical group sequential testing to allow the researcher to represent every group sequential plan as an adaptive trial design and to make design changes during the course of the trial after every interim analysis.
Journal ArticleDOI
Neoadjuvant Vinorelbine–Capecitabine Versus Docetaxel–Doxorubicin–Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial
Gunter von Minckwitz,Sherko Kümmel,P. Vogel,Claus Hanusch,Holger Eidtmann,Jörn Hilfrich,Bernd Gerber,Jens Huober,Serban-Dan Costa,Christian Jackisch,Sibylle Loibl,Keyur Mehta,Manfred Kaufmann +12 more
TL;DR: Among patients who did not respond to the initial neoadjuvant TAC treatment, similar efficacy but better tolerability was observed by switching to NX than continuing with TAC.
Journal ArticleDOI
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.
Gunter von Minckwitz,Sherko Kümmel,P. Vogel,Claus Hanusch,Holger Eidtmann,Jörn Hilfrich,Bernd Gerber,Jens Huober,Serban-Dan Costa,Christian Jackisch,Sibylle Loibl,Keyur Mehta +11 more
TL;DR: Patients receiving eight TAC cycles had statistically significantly higher sonographic response rates but not pathological complete response rates than those receiving six TACcycles, however, they also had more toxic effects.
Related Papers (5)
Designed extension of studies based on conditional power
Modification of Sample Size in Group Sequential Clinical Trials
Lu Cui,H. M. J. Hung,S.-J. Wang +2 more